Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
9.37
-0.04 (-0.43%)
At close: Nov 26, 2025, 4:00 PM EST
9.19
-0.18 (-1.92%)
After-hours: Nov 26, 2025, 4:16 PM EST

Design Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
5343491485731,183-
Upgrade
Market Cap Growth
42.61%135.41%-74.10%-51.55%--
Upgrade
Enterprise Value
33098-139233793-
Upgrade
Last Close Price
9.376.172.6510.2621.41-
Upgrade
PB Ratio
2.671.440.531.753.10-
Upgrade
P/TBV Ratio
2.671.440.531.753.10-
Upgrade
Debt / Equity Ratio
0.010.010.010.010.01-
Upgrade
Asset Turnover
-----0.01
Upgrade
Quick Ratio
18.5629.1629.4430.7672.7215.49
Upgrade
Current Ratio
18.7129.3129.5831.1072.9615.55
Upgrade
Return on Equity (ROE)
-29.83%-19.08%-22.10%-17.85%-17.08%-54.47%
Upgrade
Return on Assets (ROA)
-20.49%-14.39%-15.50%-11.55%-10.49%-28.44%
Upgrade
Return on Capital (ROIC)
-21.25%-14.85%-15.98%-11.79%-10.67%-33.49%
Upgrade
Return on Capital Employed (ROCE)
-38.70%-25.60%-27.90%-20.50%-9.30%-24.40%
Upgrade
Earnings Yield
-12.64%-14.19%-45.05%-11.05%-3.00%-
Upgrade
FCF Yield
-9.82%-12.44%-39.63%-9.12%-2.61%-
Upgrade
Buyback Yield / Dilution
-0.66%-1.08%-0.50%-21.27%-190.80%-2.08%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q